Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Topical Rho-kinase (ROCK) Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy

NCT06960629 is registered in ClinicalTrials.gov with University Hospital Dubrava as lead sponsor.

NCT NCT06960629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06960629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Topical Rho-kinase (ROCK) Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy
Lead sponsor
University Hospital Dubrava
Phase
Phase 2/3
Overall status
Completed
Start date
May 12, 2025
Completion date
May 1, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, pseudophakic bullous keratopathy